Author pages are created from data sourced from our academic publisher partnerships and public sources.
Baseline characteristics of patients with atrial fibrillation: the AFFIRM Study.
BACKGROUND Although anticoagulation therapy is accepted for most patients with atrial fibrillation, 2 different strategies exist for management of the cardiac rhythm: atrial fibrillation is allowed… Expand
Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke prevention in Atrial Fibrillation III Randomised Clinical Trial
Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry.
The TIMI 9 Registry set out to assess the management strategies and outcomes of an unselected group of patients with acute myocardial infarction presenting with ST segment elevation (STEMI).… Expand
755-2 Current Management of ST Elevation Myocardial Infarction and Outcome of Thrombolytic Ineligible Patients: Results of the Multicenter TIMI 9 Registry
Despite clear benefit of thrombolysis (Tlysis) and primary (1°) PTCA for acute MI, prior reports have indicated a low use of thrombolytic therapy in the U.S. Further, single center reports have… Expand
Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction.
BACKGROUND The Cardiac Arrhythmia Suppression Trial (CAST) tested the hypothesis that the suppression of asymptomatic or mildly symptomatic ventricular premature depolarizations in survivors of… Expand
A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in…
- C. Cannon, C. McCabe, +7 authors J. Anderson
- Journal of the American College of Cardiology
- 1 April 1994
OBJECTIVES The purpose of this study was to assess the value of recombinant desulfatohirudin (hirudin) as adjunctive therapy to thrombolysis in acute myocardial infarction. BACKGROUND Failure to… Expand
A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome.
OBJECTIVE To provide a preliminary assessment of the efficacy and safety of fludrocortisone acetate treatment of chronic fatigue syndrome. DESIGN A placebo-controlled, double-blind,… Expand
Impact of a thrombolysis research trial on time to treatment for acute myocardial infarction in the emergency department.
- C. R. Boisjolie, S. Sharkey, +4 authors T. Henry
- The American journal of cardiology
- 15 August 1995
Because time to treatment in AMI is a critical factor in long-term outcome, it is important that complex trials designed to improve reperfusion therapy do not delay the time to treatment.… Expand
Towards lean procurement: Challenges and opportunities
- J. Mark Haugland
- 3 June 2015
Rheological Measurements of Cementitious Suspensions Using a Grooved Measuring Device
When measuring the rheology of concentrated suspensions using a concentric cylindrical configuration, having a smooth surface, the results have been found to be prone to slippage. By using a modified… Expand